Skip to main content
logo
MaaT Pharma SA (EPA:MAAT)
France flag France · Delayed Price · Currency is EUR
2.735
-0.055 (-1.97%)
Sep 11, 2026, 5:35 PM CET

MaaT Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
52771118179132
Market Cap Growth
-12.33%-29.96%36.57%2.32%-40.01%-
Enterprise Value
4477975949123
Last Close Price
2.734.817.966.988.0013.35

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.3917.1234.3936.3555.35135.75
PB Ratio
28.6543.0610.703.962.953.31
P/TBV Ratio
--12.914.243.093.38

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
9.7516.9830.0526.4134.22126.09

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
9.699.691.540.690.420.15
Net Debt / Equity Ratio
-4.13-4.13-0.41-0.50-0.89-0.94
Net Debt / EBITDA Ratio
0.250.250.150.521.804.30
Net Debt / FCF Ratio
0.460.460.180.521.814.59
Asset Turnover
0.110.110.080.050.030.03
Inventory Turnover
23.3523.3512.717.4116.05-
Quick Ratio
1.871.871.812.654.389.93
Current Ratio
1.941.941.902.784.5710.05
Return on Equity (ROE)
-511.92%-511.92%-187.68%-83.41%-41.14%-32.33%
Return on Assets (ROA)
-44.75%-44.75%-43.64%-28.44%-18.00%-15.08%
Return on Capital Employed (ROCE)
-107.80%-107.80%-118.70%-63.50%-38.20%-19.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-60.27%-40.10%-26.13%-24.34%-17.32%-6.83%
FCF Yield
-31.68%-21.07%-20.61%-24.40%-16.76%-6.19%
Buyback Yield / Dilution
-21.97%-21.97%-14.95%-14.89%-307.65%-135.06%